IRF2 and neoplasm: No significant differences were noted between IRF-2 expression and other clinicopathological variables such as age, gender, tumor site and size, TNM stage, tumor infiltration, lymph node metastasis, and differentiation, preoperative serum CA19-9 or histological type.